ZTS

ZOETIS INC

ZTS·98978V103·US·Common Stock·Healthcare - Drug Manufacturers - Specialty & Generic-13D/G

ZTS (ZOETIS INC) is held by 332 institutional investors as of Q2 2026. Largest holders: BlackRock, Inc. ($2.8B), VANGUARD CAPITAL MANAGEMENT LLC ($1.9B), VANGUARD PORTFOLIO MANAGEMENT LLC ($1.7B). Net institutional sentiment: Mixed. In Q2 2026, 8 members of Congress and 156 funds bought ZTS.

332
Holders
(30 Elite)
$24.7B
Total Value
45% (345)
Consensus
156 buying - 189 selling
13F: Insider & Congress: Updated regularly
ZTS

Smart Money Verdict

View all
Loading verdict
Held by 332 funds
30 elite

Who's Trading

Source dates: Price Sep 4, 2026 · Insiders Jun 11, 2026 · Activists Jul 30, 2026 · Congress Jul 15, 2026

ActivistBlackRock, Inc.BlackRock, Inc.9.0%Jul 30, 2026
CongressGilbert CisnerosGilbert CisnerosBuy $1,001 - $15,000Jun 16, 2026
InsiderMBMCCALLISTER MICHAEL BGift 1K shJun 10, 2026
Checking access…

Top Holders

Checking access…
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
39.4M(+10.8%)$2.8B0.0%-49.08%
35
Decreased
26M(-0.2%)$1.9B0.0%-35.14%
0
Decreased
23.9M(-0.5%)$1.7B0.1%-35.14%
0
Increased
19.7M(+1.8%)$1.4B0.0%-59.41%
32
Unchanged
15.9M$1.1B0.8%-4.71%
0
Increased
13.3M(+17.1%)$951.8M0.1%-36.63%
37
Decreased
9.4M(-7.2%)$677.2M0.1%-47.24%
0
Decreased
8.9M(-37.2%)$638M0.0%-53.50%
0
Increased
6.6M(+12.4%)$471.7M0.4%-40.42%
42
Increased
5.9M(+5.8%)$420.5M0.1%-46.36%
40
Decreased
5.5M(-0.1%)$398.3M0.0%-35.36%
0
Increased
5.5M(+56.0%)$396.9M0.0%-42.70%
44
Decreased
5.4M(-1.9%)$386.7M0.3%-38.09%
0
New
4.2M$302.6M1.4%+6.23%
71
Increased
4M(+7.7%)$287.7M0.0%-33.13%
33
Increased
4M(+26.0%)$286.6M0.1%-43.57%
38
Decreased
3.9M(-10.8%)$282M0.1%-45.90%
0
Decreased
3.9M(-18.8%)$282M0.0%-51.25%
0
Increased
3.6M(+30.1%)$261.8M0.0%-45.61%
39
Decreased
3.6M(-2.3%)$256.4M0.1%-34.21%
0

Showing 1-20 of 362

1 / 19
ZTSZTSZOETIS INC

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used